Webinar: How well are you conducting your virtual meetings and webinars?
2021-07-07 10:00 - 11:00 (Europe/London)
In a world where the majority are working remotely, the ways we present ourselves has changed. But whether we are talking about delivering client-facing webinars or meetings, or even internal team meetings via video software, it is vital that we continuously improve our approach and performance in order to deliver an inspiring and engaging experience for our audience.
COVID-19 has changed so much in our business lives and online communication has become the norm. From a business perspective we are now spending much of our day talking to colleagues or customers online, and from a marketing perspective, webinars have replaced conferences, and even were conferences are taking place, the virtual partnering platforms often require online video conferencing.
The Life Sciences Marketing Special Interest Group will cover best practice for delivering brilliant presentations and conducting excellent meetings to help you promote yourself and your business. This webinar will be of value to all who have to, or might have to, create and deliver business presentations, webinars or hold meetings as part of their current role – and who want to be the best at it!
The webinar will cover:
-The types of virtual meetings and webinars
-Current industry challenges
-The best approach for delivering engaging meetings and webinars
-The purpose and nature of presentations.
-Knowing what success looks like and the need for clearly defined outcomes.
-It’s all about the audience!
There will also be an opportunity to put your questions to our presenters in a Q&A session.
This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the INSTILS programme, this event is not restricted to those in the D2N2 area.
DURATION: 1 HOUR

Robin Bodicoat, Marketing Director at Quotient Sciences
Robin is the CIM qualified, Marketing Director at Quotient Sciences, a leading drug development services organization. He is also an active Board Member of the BMC (Business Marketing Club), which is the independent voice of the B2B marketing industry. He has 15+ years’ experience in Life Sciences, Pharma and Healthcare, with knowledge in marketing campaign planning and strategy, and brand development. In 2017 he managed the global re-brand of Quotient Sciences.

Lizzie Butler, Founder & Creator, LB Communications Ltd
Lizzie Butler is the founder and creator of LB Communications – an exciting business that shares the most essential communication skills for corporate and individual development!
With over 20 years’ experience working for blue-chip companies, not-for-profit organisations and the public and private sectors, she helps individuals and businesses to enhance their skills, grow their businesses and develop their teams through brilliant communication.
As a Licensed Master Practitioner of NLP and a highly experienced Business Development Specialist, Lizzie has worked with Executive Directors, Business Owners, Sales Professionals, Commercial Managers, Lawyers, Event Managers, University Lecturers and Students, creating change, development and corporate and individual growth!

WEBINAR: The MindTech Method: improving your chance of success in digital mental health
2021-07-08 11:00 - 12:30
Digital mental health is an attractive space for SMEs as it offers not only the potential to do good but to do it in new and innovative ways. Despite digital health being a billion-pound industry, many companies struggle as they face challenges in evaluation and barriers to implementation. On the app store there are thousands of mental health offerings but very few are evidence-based and sustainable. Our mental health system is under immense pressure with a lack of coverage for specific care and long waiting lists. There is both the need and the enthusiasm, so why is it still so difficult?
MindTech is a national centre, funded by NIHR, focusing on the development, adoption and evaluation of new technologies for mental healthcare and dementia. MindTech specialises in applications of digital technologies such as computerised therapies and diagnostics, deployed on smartphone apps, wearables and virtual reality, as well as medical devices and assistive technologies. For the past 8 years, and alongside their Involvement Team who bring expertise by experience, they have been working with industry, academia and the NHS to meet the unmet needs of patients, families and professionals through new technologies.
This webinar will provide an overview of MindTech’s research and will share the lessons they have learned through these collaborations from development all the way through to adoption. It will highlight how researchers and companies can work with each other and the NHS to develop and evaluate high quality evidence-based digital mental health interventions that lead to real world adoption.
MindTech is especially pleased to showcase case study presentations from three of their industry partners:
– BfB Labs: From problem space to solution to implementation can be a long road. BfB Labs will share their journey to rolling out a multi-award winning ‘Digital therapeutic app’ (CE marked medical device)
– ProReal: Avatar therapy and virtual world technology in mental healthcare
– QbTech: Highlighting the support that they had to achieve their many successes
After the presentations there will be a Q&A .
DURATION: 1.5 hours
This webinar is brought to you by the National Institute for Healthcare Research MindTech MedTech Co-operative, organised and delivered by Medilink Midlands and funded through a University of Nottingham Small Business Engagement Award.
Speaker Profiles:

Dr. Michael Craven, Principal Research Fellow, NIHR MindTech MedTech Co-operative
Mike leads the Technology, Design and User Experience theme within MindTech. At the University of Nottingham he is a member of the Bioengineering research group in the Faculty of Engineering and the Institute of Mental Health’s Centre for Dementia. Mike contributes expertise in design and evaluation of digital health, medical device related interventions and assistive technologies. He conducts health technology assessments for NHS organisations and industry and contributes to policy on digital mental health. Currently, he is co-investigator on several of MindTech’s large collaborations and trials of technologies which include evaluation of cognitive training software, remote/mobile mental health and virtual reality therapy, and various co-design projects with patients and healthcare professionals.

Dr Aislinn Bergin, Research Fellow, NIHR MindTech MedTech Co-operative
Aislinn is primarily working on the gameChange project – an automated VR therapy for people with psychosis – where her research focuses on the implementation and sustainability of complex interventions.
Aislinn has a PhD in Digital Mental Health and a BA (Hons) in Developmental Psychology. Previous research has covered the use and development of digital mental health which led her to research that could help ensure high quality evidence-based digital mental health is adopted into the health and social care economy. She has previously worked as research manager at a local Healthwatch ensuring that peoples’ voices are heard in health and social care, which provided her with significant insight into how local health economies function.

Rebecca Woodcock, Patient and Public Involvement Co-ordinator: Mental Health & Technology Research, NIHR MindTech MedTech Co-operative
Informed by a career championing diverse voices in the charity sector and benefiting from a recent MSC in Voluntary Sector Management, Rebecca brings both passion and personal lived experience to supporting patient and public involvement.
Her role involves developing and delivering our Involvement strategy, whilst working with colleagues across the Institute of Mental Health, other Biomedical Research Council (BRC) themes, national bodies and industry partners to support the implementation of best practice within PPI.
As well as working with Researcher to develop and refine their PPI strategies, Rebecca has recently co-produced a framework for supporting digital PPI and worked with PPI colleagues and public contributors to present at the MindTech Annual Conference.

Dr Charlotte Hall, Senior Research Fellow, NIHR MindTech MedTech Co-operative
Charlotte’s main areas of interest include the implementation of technology to support the assessment, monitoring and treatment of mental health disorders within children and young people, particularly in neurodevelopmental disorders.
Charlotte has specific expertise of the design, conduct and management of clinical trials in community child mental health services and child and adolescent mental health services (CAMHS) and is interested in the nuances in online trail delivery.
Charlotte is trial manager for the ORBIT study, which is evaluating the remote digital intervention for tics. Amongst other studies, Charlotte is also a co-investigator on the FACT trial, assessing the use of the QbTest for young people in prison (led by Dr Chitsabesan at the University of Manchester), the QUOTA Trial assessing QbTest or medication management (led by Dr Maddie Groom at the University of Nottingham) and the SATURN trial which looks at medication for children with ADHD and tics. Charlotte is also acting as site lead for the OPTIMA Trial, investigating the online delivery of a parent ADHD intervention and is principal investigator on the WAIT study looking at waiting list interventions in CAMHS. She was also the trial manager on the AQUA Trial which investigated the clinical and cost-effectiveness of the QbTest, the findings of which are being implemented in routine practice.

Dr Jen Martin, Senior Programme Manager, NIHR MindTech MedTech Co-operative
Jen has worked in the healthcare technology field for more than 20 years and is currently MindTech’s Senior Programme Manager. Prior to this, Jen was Senior Research Fellow in Human Factors at the University of Nottingham. Jen’s interests lie in the development, evaluation and adoption of mental health technologies such as Virtual Reality, games and digital interventions.
Jen is a co-investigator on the NIHR-funded gameChange project which is using VR to transform the lives of people with psychosis, and leads the implementation workstream within this. She is a member of NHS England’s Expert Reference Group for Digital Innovation and Adoption and is also an advisor to NICE as part of their work on accreditation of mobile health apps.

Manjul Rathee, CEO, BFB Labs
Manjul is an impact entrepreneur, with deep expertise in service design & product innovation in a variety of sectors (including health tech, youth welfare, wellness travel and more). She is the CEO of BFB Labs, a highly innovative mental health tech company developing cutting edge digital therapeutics for better youth mental health, and the Co-founder of sight loss public health initiative Eye Heroes. She has a Masters in Sustainability, and has led the development of multi-award winning digital products/services and taking them to market nationally and internationally.

Andrew Jackson, Chief Executive, ProReal
As a Partner at PwC and an Executive in IBM, Andrew has over 25 years’ experience supporting organisations and people through change. Curious about coaching and technology, Andrew was the co-founder of ProReal Ltd, a company and a team who believe in a world where relationships and sense-making are built on more than words. They have developed an avatar-based 3D visualisation technology to help people tell their stories and share how they see the world. ProReal’s research programme describes the technology’s adoption in healthcare, prisons, schools, and social care settings, and by several NHS Trusts.

Jo Barosa, Account Director, QbTech and UK & Operational Lead for the National Programme Focus ADHD
Working for over 2 decades in the ADHD arena, 10 of them at Qbtech, Jo is passionate about improving outcomes for children and adults by consulting on ADHD care pathways and supporting clinicians, services and Trusts with business plans, clinical information and governance and procurement considerations to secure additional funding needed to support positive change, including adoption of objective testing (QbTest).

VIRTUAL COFFEE BREAK - East Midlands Academic Health Science Network
2021-07-13 12:30 - 13:30
Join EMAHSN for an informal virtual coffee break on Tuesday 13 July at 12:30pm, we will be joined by Victoria Townshend who is a Lead Change Manager for Lincolnshire Sustainability Transformation Partnership (STP). Victoria will be providing insight in regard to her role and responsibilities from an NHS commissioning and wider NHS landscape perspective as well as tips for innovators who are looking to engage with the Healthcare system. This informal gathering will provide you with the opportunity to share your experiences and ask questions.
Networking opportunities are a key part of Medilink Midlands events and whilst the current COVID-19 crisis still restricts face to face events, this online opportunity enables the life sciences community to still connect with one another.
Grab a coffee, a biscuit and join us.
Joining details will be provided to delegates by a member of the Medilink Midlands events team once the online registration form has been completed.
If you have any topics that you’d like to discuss in future EMAHSN coffee breaks, please feel free to email any suggestions to us by clicking here.

Chair: Julian Patel, Commercial Manager EMAHSN

Aisha Ajij, Project Support and Industry Liaison Officer, EMAHSN

Guest Speaker: Victoria Townshend, Lead Change Manager, Lincolnshire Sustainability Transformation Partnership (STP)

Medilink Midlands Virtual Coffee Break (Members-Only)
2021-07-14 10:30 - 11:30
Join us for our next Members-Only Virtual Coffee Break, taking place on 14 July from 10:30am – 11:30 am.
The informal gathering will be hosted by Darren Clark, Chief Executive at Medilink Midlands. These online coffee breaks provide an opportunity to share current challenges and experiences and make introductions to those that can help.
The theme for this coffee break will be ‘How has Brexit impacted your Business?’ . We will be joined by Alex Mclaughlin, Head of International Trade and Medical Device Regulation, Office for Life Sciences, who will provide a short update.
We’re here to help, so let Medilink along with the virtual group work together to help each other with any concerns, issues, or solution needs you may have. If you have any questions or comments, please feel free to submit in advance to make sure we cover your needs and meet expectations. Click here to submit.
Dial-in details will be provided to delegates by a member of the Medilink Midlands events team once the online registration form has been completed.
Medilink Members only.

CHAIR: Dr Darren Clark, CEO, Medilink Midlands

GUEST SPEAKER: Alex Mclaughlin, Head of International Trade and Medical Device Regulation, Office for Life Sciences

WEBINAR: Hospital-based Health Technology Assessment (HTA): What medical device manufacturers should know
2021-07-15 10:30 - 11:30
Join this one hour webinar to hear from the team at CHEATA (The Centre for Healthcare Equipment & Technology Adoption) if you want to learn about hospital-based Health Technology Assessment (HTA).
During the webinar Professor Dan Clark OBE and Dr Sarah Bolton will cover:
– What is Hospital-based HTA
– Two case studies from Nottingham University Hospitals NHS Trust
– What evidence should medical device manufacturers be thinking about to support HTA
About CHEATA: CHEATA was set up within the Department of Clinical Engineering at NUH NHS Trust in response to the challenge laid out in “Innovation Health and Wealth – Accelerating Adoption and Diffusion in the NHS” to help the NHS become the best health system in the world by rapidly adopting new devices and technologies into practice. CHEATA is hosted by Clinical Engineering service at Nottingham University Hospitals NHS Trust.
DURATION: 1 Hour
This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the INSTILS programme, attendance is not restricted to companies in the D2N2 region and is open to all.
Speaker Profiles:

Professor Dan Clark OBE, CHEATA Director and Head of Clinical Engineering at Nottingham University Hospitals (NUH)
Dan leads the Clinical Engineering service at Nottingham University Hospitals, one of the largest in Europe, which provides the full scope of equipment services including: device evaluation, commissioning, service and maintenance, decommissioning and disposal. He has considerable experience of evaluating new technologies and medical devices and introducing them into the healthcare setting. Dan also holds an honorary chair in the Faculty of Engineering at the University of Nottingham and is co-director of the Centre for Healthcare Technologies, a unique collaborative venture between Nottingham University and NUH NHS Trust specialising in the acceleration of curiosity driven science into adopted medical technology. He also chairs the NUH NHS Trust’s Medical Devices Group and sits on a number of trust-wide risk committees. Finally, Dan was an expert member of the NICE Medical Technology Advisory Committee (MTAC) for 10 years until his “retirement” from the committee in 2019. Dan is a director and founder member of CHEATA since its inception in late 2014. Dan was awarded an OBE for Services to Clinical Engineering particularly during Covid-19 in the 2021 New Years Honours.

Dr Sarah Bolton, CHEATA Business Manager
Sarah has been the Business Manager for CHEATA since August 2016. Prior to joining CHEATA, Sarah was responsible for Healthcare and Medical Devices at Pera Technology, a role which included project delivery, client engagement and management, project planning and management as well as bid writing for major UK and EC funding bodies. Sarah is an experienced research scientist with a background in academic and clinical inflammation research where she undertook her post-doctoral studies on inflammatory mechanisms in the brain and activation mechanisms of eosinophils in asthma. She joined AstraZeneca in 2004 as an Experimental Pathologist in the Respiratory and Inflammation Therapy area, specialising in translation pathology of COPD and asthma. After leaving AZ, Sarah worked as an independent consultant continuing the experimental pathology work for a range of academic and commercial clients.

WEBINAR: BREXIT: Navigating the Maze of Business Travel & Working in the EU
2021-07-16 10:00 - 11:30
Join this Medilink Midlands webinar in partnership with Make UK to find out what changes companies need to consider in respect of the UK’s new immigration system and the new relationship with the EU as set out in the UK-EU Trade and Cooperation Agreement (TCA).
The ability for UK business visitors to travel to the EU on work-related matters has changed.
With the end of freedom of movement business travel between the EU and the UK will no longer be as easy as it once was.
The UK and the European Union have negotiated and agreed a new Trade & Cooperation Agreement (TCA) and the transition period ended on 31 December 2020 with the UK leaving the EU Single Market and Customs Union. This means there are significant and immediate changes for businesses trading with the EU and Northern Ireland.
New arrangements for UK business visitors to travel to the EU on work-related matters came into effect from 1 January 2021. The UK not being a member of the EU is now a ‘third-country’ and UK employers have to navigate individual EU member state rules for their mobile workforce.
PLEASE CLICK HERE TO SECURE YOUR FREE PLACE
The webinar will cover;
1.UK/EU Trade Agreement
-What does the TCA mean for the UK?
-Trade in services
-People services
2.Movement of people
-Worker definitions under the TCA
-Business visitor for establishment purposes
-Independent professionals
-Contractual service suppliers
-ICT – Intra-Corporate-Transfers
-Short term business visitors
*Permitted activities
-UK employers – self-employed, contractors & agents
3.Professional qualifications
-Mutual recognition of professional qualifications
4.Social Security
-Social security rules
5.Penalties, fees and fines
6.Planning for travel
-Where to start
-What you need to know about your workforce
-What you need to know about EU immigration systems
-Visa free travel to the EU
7.Case study – Germany
8.Working in the UK
9.Routes
Followed by Q&A session
DURATION: 90 minutes
PLEASE CLICK HERE TO SECURE YOUR FREE PLACE
Speaker Profiles: to follow

Virtual Workshop: Introduction to NHS Market Access
2021-07-27 12:30 - 13:30
REGISTRATION FOR THIS EVENT IS NOW CLOSED

Join our two-part CPD accredited virtual workshop, Introduction to NHS Market Access, delivered by the East Midlands Academic Health Science Network (EMAHSN).
Combined, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS.
PART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you.
The webinar will cover:
– The NHS Structure
– Understanding pathways and cash flow
– Getting your message right
– What support you can expect from the AHSN
——————
PART 2 is a live 1-hour Q&A session that will take place on Tuesday 27th July.
In order to gain access to this live session, delegates are required to watch the pre-recorded webinar prior to attending.
The Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team.
Upon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team. Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.
SPEAKER PROFILE:
Live Q&A Chair:

Tim Robinson, Commercial Director, East Midlands Academic Health Science Network

Pre-recorded Webinar:
Nicholas Brown, Commercial Manager, East Midlands Academic Health Science Network
Nick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this, Nick has more than 20 years’ experience of the medical industry working with manufacturers, distributors and clinical staff from the UK and European health sectors, from both the sales and marketing side, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region .

VIRTUAL WORKSHOP: Is your Business Case NHS Ready?
2021-08-05 10:30 - 11:30
Registration is now closed
Join the second of our two-part CPD accredited virtual workshops, Is your Business Case NHS Ready?, delivered by the East Midlands Academic Health Science Network (EMAHSN).
The challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case.
PART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you.
The pre-recorded webinar will cover:
– What a business case is, what is its purpose and why is it so important?
– Who reviews the business case and how are they evaluated?
– How to construct a good business case
——————
PART 2 is a live 1-hour Q&A session on Thursday 5th August at 10.30am.
In order to gain access to this live session, delegates are required to watch the pre-recorded webinar prior to attending.
The Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team.
Upon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team. Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.
Speaker Profiles:

Live Q&A Session Chair: Tim Robinson, Commercial Manager, EMAHSN

Mike Watson, Digital Lead, EMAHSN

Live Q&A Session Support: Aisha Ajij, Project Support and Industry Liaison Officer, EMAHSN

Pre-recorded webinar: Nicholas Brown, Commercial Manager, EMAHSN (note, Nicholas no longer works for the EMAHSN)

VIRTUAL: Fourth Annual Conference on Innovation & Trade: Mentor Means Business
2021-09-08 13:30 - 16:00
The Northeast Ohio region is home to some of the leading medical institutions in the United States, including the Cleveland Clinic, and the region has developed one of the nation’s most important biomedical clusters.
Over 700 biomedical firms are located there, including over 400 medical device manufacturers specialising in imaging, neuro-stimulation, orthopaedics, cardiovascular, and sterilisation.
Internationally recognised clinical research institutions, including the prestigious Cleveland Clinic, University Hospitals, and Case Western Reserve University, provide Mentor biomedical and med-tech companies a world-class platform for research, design, and innovation.
On 8 September, 2021, learn more about the advantages of doing business in Northeast Ohio and the City of Mentor by participating in a virtual conference focused on Ohio’s medtech innovation corridor.
Conference activities include:
– Discussion with experienced legal advisors on setting up your US business operations and positioning your company for success in the North American market
– Guidance from high-level US hospital system personnel on the particulars of getting your products and services into the US healthcare system
– Direct interaction and potential dialogue with US companies and officials that can help you bring your products and services into the United States
View the programme and further details here
To register online, click here

IN-PERSON EVENT: IP Strategy for Medical Devices
2021-09-09 09:00 - 13:00 | We are Pioneer Group Nottingham, Innovation Building, (formerly BioCity), Pennyfoot Street, Nottingham, NG1 1GF, United Kingdom
With COVID-19 restrictions being eased for business events, we are pleased to be able to offer this in person event. Please see details below regarding COVID-19 compliance.

Attend this event to hear from AdamsonJones, limited spaces available – book early to avoid disappointment.
This event has been designed for companies developing innovative medical devices to learn how to navigate complex patent landscapes in the medical devices sector and to learn about strategies for increasing the value of their own patent applications and other IP.
Topics include:
– Patent searches and R&D
– Navigating patent landscapes
– Identifying inventive concepts
– Patent filing strategies
– Attracting investment
– Enforcement
– Design registrations
– Trade marks
Programme
Speaker Profiles
Delegate List
The venue and all participants will be required to adhere to social distancing guidelines at all times. Please see further information below regarding COVID-19 compliance at the venue.
We are Pioneer Group, Nottingham (formerly BioCity):
We are Pioneer Group is accessible by car, train and bus as it is a City Centre venue, on-site parking is not available for delegates, however the Motorpoint Arena Car park is available and located behind the buildings, for details and the address see here.
Venue and event – COVID-19 Compliance
– Delegates must not attend if they are self isolating or displaying any COVID-19 symptoms (a high temperature, new and persistent cough, or a loss of/change in sense of taste or smell), even if these symptoms are mild
– Delegates must not attend if anyone they live with have one of the above symptoms
– An NHS QR code for delegates to check in on will be available
– Delegates/staff have the option to wear a face covering upon entering the venue and whilst in attendance at the event
– The room will be laid out with relevant spacing between tables/delegates
– All rooms will have hand sanitiser nearby
– Social distancing measures will be in effect for all toilets
– Individual boxes will be provided for lunch – with options for Meat eaters, Vegetarian, Vegan and Gluten Free

WEBINAR: How are you ensuring you're plugging the future skills gap in Life Sciences?
2021-09-14 10:00 - 11:30
In this Medilink Midlands webinar, We are Pioneer Group will discuss whether there is a life science skills and infrastructure gap in the Midlands? Where are the opportunities and What can we do about it?
The life sciences industry is continuing to boom, with new technologies and locations changing not only how professionals are working but where. The health and life sciences sector already provides jobs for nearly 256,000 people across the United Kingdom, but ongoing growth and strategic transformation means demand for new skills and experienced personnel is only expected to grow in the coming years.
Could this mean a life science skills and infrastructure gap for the Midlands? What can we do as a collective to prepare?
The webinar will address:
-How we can ensure we have the talent in place – from clinical pharmacologists, to bioinformaticians to innovators in medicine development?
-How do we capitalise on the hubs we already have for working in and what’s needed in the future?
-What infrastructure is missing?
Presentations will be followed by a Q&A session.
Speaker Profiles:

Toby Reid, Executive Director, We are Pioneer Group (Chair)
Toby has managed and run life science-focused properties and ecosystems for the last ten years. He has a background in engineering and project management as well as business start-up and venture capital finance. Toby leads on creating the environment that helps tenant companies scale and grow.

Professor Mike Hannay, Managing Director, Medical Technologies Innovation Facility (MTIF)
Mike is Managing Director of MTIF based in Nottingham. Funded by Nottingham Trent University and D2N2 Local Enterprise Partnership MTIF works with partners across the East Midlands to improve the quality of patient care by helping Med-Tech companies accelerate the development and commercial availability of innovative medical technologies and devices.

Professor Claire Thompson, CEO, Agility Life Sciences
Claire is a multi-award winning scientist, strategist and storyteller with more than 20 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual biotech and Contract Development and Manufacturing Organisations (CDMOs). She is CEO of Agility Life Sciences, an award-winning CDMO, consulting and communications firm which works with organisations across the healthcare space to fast track their products to market, raise investment and help them to convey the benefits of their science through impactful communications.
She is also Entrepreneur in Residence at the University of Cambridge. Claire holds an Honorary Professorship from the School of Pharmacy at the University of Nottingham, and is Chair of the International Pharmaceutical Federation’s Women in Science and Education (FIP WiSE) initiative.

Robin Weir, Head of China Practice, Facey Associates LLP, Hong Kong
Managing Director, Turkington Tang Limited
Robin is head of the China practice at Facey & Associates LLP, a boutique law firm in Hong Kong, having lived for 13 years in mainland China. He is also managing director of Turkington Tang, a consultancy which advises on international business including cross-cultural management issues.

VIRTUAL WORKSHOP: Creating Valid Evidence & Evaluation for the NHS for Medical Devices
2021-09-15 10:00 - 11:00
***REGISTRATION FOR THIS EVENT IS NOW CLOSED***
Join the third of our two-part CPD accredited virtual workshops, Creating Valid Evidence & Evaluation for the NHS for Medical Devices, delivered by the East Midlands Academic Health Science Network (EMAHSN).
This session will provide an overview about the kinds of evidence and evaluation that the healthcare system really wants in order to support their buying decisions.
This is the third part of the 3 session CPD accredited workshop series designed to get you ready to successfully secure business with NHS organisations
PART 1 is a pre-recorded webinar that you can watch at a time convenient to you.
The pre-recorded webinar will cover:
• Evidence needed for regulatory purposes
• Principles and models of evaluation and principles of study design for evaluating healthcare interventions, to outline the value proposition of the innovation
——————
PART 2 is a live 1-hour Q&A session on Wednesday 15th September 10:00am – 11:00am
In order to gain access to this live session, delegates are required to watch the pre-recorded webinar prior to attending.
The Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team.

Upon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team. Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.

SPEAKER PROFILES:
Julian Patel, Commercial Manager, East Midlands AHSN

Aisha Ajij, Project Support & Industry Liasion Officer/ITP – AAC Delivery Lead, East Midlands AHSN

Philip Miller, Evaluation Researcher, East Midlands AHSN

Dr Sarah Bolton, Business Manager, The Centre for Healthcare Equipment & Technology Adoption (CHEATA)

WEBINAR: Medtech Regulatory Special Interest Group (SIG) – Product traceability and Unique Device Identification for the EU and Global Use
2021-09-16 13:00 - 14:00
The next MedTech Regulatory Special Interest Group (SIG), delivered by regulatory affairs expert Richard Young and GS1 standards professional Chris Florey, will explore the requirements for product traceability and Unique Identification for the EU and Global Use, immediate and future considerations for a business.
This webinar will cover:
Richard Young, AcclaimBiomedical Consulting Ltd:
– Regulatory background
– Eudamed
– MDCG guidance so far
Chris Florey, GS1 standards professional, GS1 UK:
– Basic UDI DI (GMN)
– UDI-DI and UDI-PI
– UDI for software as a medical device
– Human Readable Interpretation (HRI)
– Barcode verification
There will be time at the end of the presentations for a Q&A session. Please submit any questions in advance for Richard and Chris to discuss during the presentation on the online booking form.
This free-to-attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the ACTIS programme, attendance is not restricted to companies in the SEMLEP area and is open to all.
Duration: 1 hour
TO BOOK YOUR FREE PLACE, CLICK HERE
Speaker Profiles:

Richard Young, Managing Director, AcclaimBiomedical Consulting Ltd
Richard has an extensive background in regulatory affairs in addition to GMP (quality assurance), GLP (laboratory testing), and GCP (clinical). Spanning over two decades, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots, through electromedical devices such as infusion systems and cardio vascular products.
Richard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions.
Richard’s skills and experience includes such areas as the development and implementation of effective quality management systems, auditing to ISO and FDA QSIT standards, and operating at national and international level through industry associations including Eucomed, ABHI and ABHI Technical Policy Group.

Chris Florey, GS1 standards professional, GS1 UK
Chris has over 15 years experience of working with organisations to adopt GS1 standards to meet trading partner and regulatory requirements, and his focus for the past eight years has been within the healthcare industry, assisting medical device and pharmaceutical manufacturers in implementing the NHS eProcurement strategy, the FDA UDI rules, the EU MDR and the FMD using GS1 standards. Whilst not a regulatory expert, he is able to share his experience of engaging with the regulators and thousands of manufacturers and distributors that are GS1 UK members.

*Cancelled* WEBINAR: The Midlands Ecosystem of Bench to Bedside in the Era of MDR and UKCA
2021-09-21 10:00 - 11:30
**Unfortunately this event has been cancelled due to unforeseen circumstances. We anticipate that it will take place in early 2022, details to be released in our fortnightly newsletter in due course**
The MedTech and medical devices market for the UK has changed. Companies large and small, having weathered the impacts of COVID-19, are now faced with further challenges as the EU’s MDR comes into effect and we march towards the time limit on marketing CE marked devices and in vitro diagnostics within the UK and the introduction of the UKCA. These changes present opportunities but companies will have to be prepared if they are to remain profitable, whilst both maintaining compliance and in achieving compliance for their new devices and diagnostics.
Fortunately the Midlands boasts a thriving ecosystem of MedTech organisations, networked to provide end to end support for driving innovations from “bench to bedside”. Companies within the Midlands have a multitude of development services which they can access to help take them from ideation to regulation. This webinar in partnership with the Medical Technologies Innovation Facility (MTIF) aims to highlight these services and map out how to both access them and get the most out of that interaction.
There will be an opportunity to put your questions to the presenters in a Q&A session after the presentations.
Duration 1 hr 30 mins
This free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £190, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the INSTILS programme, attendance is not restricted to companies in the D2N2 area and is open to all.
Speaker Profiles

Professor Mike Hannay, Managing Director, Medical Technologies Innovation Facility (MTIF) – CHAIR
Mike is Managing Director of MTIF based in Nottingham. Funded by Nottingham Trent University and D2N2 Local Enterprise Partnership MTIF works with partners across the East Midlands to improve the quality of patient care by helping Med-Tech companies accelerate the development and commercial availability of innovative medical technologies and devices

Deanne Hewson, Healthcare Technologies Industry Manager, University of Nottingham
Deanne Hewson has worked with businesses and universities for over 20 years, developing knowledge exchange activities and providing business support. Deanne’s current role with the Centre for Healthcare Technologies focuses on delivery of the INSTILS programme, offering support to SMEs in the D2N2 region to innovate products, services and processes.

WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
2021-09-22 10:30 - 11:30
Join the next online Additive Manufacturing & 3D Printing Special Interest Group, in partnership with The University of Nottingham – Centre for Additive Manufacturing.
Confirmed presentation topics:
– Medical Product Design for Additive Manufacturing
– How to protect Intellectual Property in Additive Manufacturing innovations
– Additive Manufacturing of Medical Devices
DURATION: 1 hour
This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the INSTILS programme, attendance is not restricted to companies in the D2N2 area and is open to all.
Speaker Profiles:

Chaired by: Ruth Goodridge, Professor in Additive Manufacturing (3D Printing), The University of Nottingham
Ruth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering, she has a particular interest in the medical applications of Additive Manufacturing, including assistive and rehabilitation devices (inc. prosthetics), implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing, including a 2-year JSPS fellowship held at NAIST, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects, in particular for polymer and glass powder bed fusion.

Professor Richard Bibb, Professor of Medical Applications of Design, School of Design & Creative Arts – Loughborough University
Richard is Professor of Medical Applications of Design in the School of Design & Creative Arts, Loughborough University. He has more than 20 years’ experience in research exploring the application of Additive Manufacturing and advanced design technologies in surgery, prosthetics, orthotics and medical devices. He founded the Medical Applications Group at PDR in 1998 and led it for 10 years. He moved to Loughborough University in 2008 and founded the Digital Design & Fabrication research group in 2014.

Gareth Probert, Partner, UK and European Patent Attorney, EIP
Gareth is a partner at the patent firm EIP and heads the EIP HealthTech practice group, an interdisciplinary team specialising in protecting innovations in the medtech and healthcare sectors. He also focusses on contentious proceedings before the European Patent Office, often handling multi-party oppositions for commercially significant patents. During his 20-year career in the profession Gareth has gained substantial experience in the medtech and healthcare space, along with the FMCG, formulations, peptide, food and chemical sectors.

Dimitris Katsanis, Founder & CEO, Metron Additive Engineering
Dimitris is the founder and CEO of Metron Additive Engineering, an ISO 13485 and AS9100 certified company, active in the field of Additive Manufacturing of metallic components.
Since 2015, he leads a team of engineers and scientists working on the design and manufacturing of parts used in a variety of industries. In the field of medical implants, Metron A.E. participated in a variety of custom implants programs together with other world leading companies in the field.

WEBINAR: Infectious Diseases Special Interest Group - The Microbiome: Emerging and Innovative Technologies
2021-09-23 10:00 - 11:30
Join the next online Infectious Diseases Special Interest Group (SIG), this SIG will focus on “The Microbiome: Emerging and Innovative Technologies”.
Recent advances in microbiome research have highlighted the significant influence these microbial populations have on our wellbeing. The upcoming SIG will be focussing on this rapidly accelerating field, looking at the role of the microbiome in human health and how imbalances lead to disease. It will also look at the application of emerging technologies that can be used to better understand the microbiome, and the development of new therapeutic approaches for associated diseases.
This event is in partnership with De Montfort University and led by Dr Katie Laird, Professor of Microbiology and also Head of the Infectious Disease Research Group at De Montfort University.
Confirmed speaker presentations:
– Open Innovation in Biofilms R&D: Translation of Academic Research to Address Industry Needs
– Manipulating respiratory microbiomes: a role for commensals?
– Labskin: Commercial Skin models to understand the microbial/host interaction
– Rapid Prototyping of Microfluidic Systems
DURATION: 1.5 hours
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £190, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the SoLSTICE programme, attendance is not restricted to companies in the Leicester/Leicestershire region and is open to all.
Speaker Profiles:

Dr Katie Laird, Professor of Microbiology and Head of the Infectious Disease Research Group at Leicester School of Pharmacy, De Montfort University
Katie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.
Her research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms. Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena.

Dr Katerina Steventon, Senior Innovation Consultant, National Biofilms Innovation Centre
Katerina is a healthcare specialist with substantial experience of working at the clinical, commercial and research interface. She holds a MSc in Clinical Biochemistry, a PhD in Transdermal Absorptions and over 20 years of global work experience in the personal care and wound care industry. Katerina has an in-depth knowledge of skin biology in both its healthy and diseased states. The strengths Katerina brings to NBIC comprise a comprehensive understanding of the industry and academia, commercialisation of research in a spectrum of healthcare areas and an experience of running an innovation consultancy with a focus on functional skincare.

Dr David Cleary, Career Track Post-Doctoral Fellow, Faculty of Medicine, University of Southampton and the Southampton NIHR Biomedical Research Centre
David graduated in Medical Microbiology from the University of Surrey in 2002 and went on to complete his PhD with the University of Warwick whilst employed as a microbiologist at the Defence Science and Technology Laboratories (DSTL), Porton Down. His current research interests include characterising human respiratory tract microbiomes to determine the microbiota-host interactions that determine colonisation and progression to disease, as well as understanding the epidemiology of pathogens such as Streptococcus pneumoniae and Non-typeable Haemophilus influenzae.

Dr David Caballero-Lima, Head of R&D, Labskin
David received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. David took postdoctoral research positions at the University of Sheffield and the University of Manchester, with both roles focussing on studying human/pathogen interaction via tissue models and obtaining a greater understanding in the regulation of the cell cycle and vesicle transportation during morphological changes.
David was initially Services Manager at Labskin, bringing his 18 years’ experience working with microbiology and host-pathogen interactions. As Head of R&D, David now leads the research department, focusing on the development of new methods for studying the native skin microflora, prebiotic, probiotics and antimicrobial effects of ingredients and formulation for pharmaceutical and cosmeceutical studies. He is also the scientific lead for the development of Labskin new consumers service; Skin Trust Club. David is a key collaborator on international research bids, as a peer with leading international experts from academia and industry.

Paul Marshall, Engineering Consultant, Co-Founder of Rapid Fluidics Ltd
An experienced Chartered Mechanical Engineer, Paul lead the engineering for QuantuMDx Ltd in Newcastle to develop the Q-POC point of care mobile diagnostics system and is now an engineering consultant specialising in Life Sciences. His works covers a wide range of projects from microfluidic instrumentation and consumable systems design for diagnostics through to technical reviews of water, sanitation and health projects for the Bill and Melinda Gates Foundation.

Dr Raymond Allan, Senior Lecturer in Microbiology, De Montfort University
Raymond’s research focusses on the investigation of bacterial biofilms, developing an understanding of the adaptive mechanisms they employ to enable their survival within the human host, and their role in chronic infectious disease. His research also includes the identification of targets for the development and investigation of novel treatment strategies for biofilm-associated infections. He has several years’ experience investigating biofilms at University of Southampton, the National Biofilms Innovation Centre, and Southampton NIHR Wellcome Trust Clinical Research Facility, before joining De Montfort University.

Med-Tech Innovation Expo 2021
2021-09-28 09:00 - 2021-09-29 17:00 | NEC Birmingham, Hall 2, Birmingham, B40 1NT, United Kingdom
Medilink UK is working closely with Rapid News, organisers of Med-Tech Innovation Expo. Plans are continuously being worked on to provide a safe environment for both exhibitors and visitors. We continue to plan ahead, and continue to monitor all Government guidelines.

Med-Tech Innovation Expo is the UK & Ireland’s leading event for medical design and manufacturing technology. Discover the latest machines, technology, products and services while networking with designers, engineers, innovators and manufacturers from across the medical and healthcare sector.
Hear from industry leaders
Med-Tech Innovation Conference, in association with Medilink UK. The Med-Tech Innovation Conference is now the UK’s key annual summit for medical device OEMs, with a programme that offers high-level thought leadership from the sector’s biggest names. Produced by Medilink UK, the Conference stage has played home in the past to leading figures from Boston Scientific, Roche Diagnostics, NHS England, Innovate UK, and the MHRA to name just a few.
Learn about the regulatory and market access challenges and opportunities from those with senior-level insights. Take the opportunity to question policymakers and influencers, and network with a first-class line up of speakers.
Exhibit – increase visibility, credibility and sales
– Your stand is the platform to generate hot new leads and engage with existing customers; accelerating your sales process and supporting business growth plans. Visitors are highly engaged, many with direct purchasing power and the intention to do business on the day.
– With thousands of visitors from the medical engineering, design and manufacturing community, you will meet decision makers and influencers from designers and project engineers to research and development and production professionals.
– As an exhibitor, you will have the opportunity to increase brand awareness, boost your profile in the industry, meet suppliers who will help your business grow and learn about innovative new developments in the world of medical technology.
Medilink members receive a 15% discount on exhibition stands
Current confirmed Medilink members exhibiting as part of the Medilink UK Pavilion, B70/B88:
– Accelerate Associates
– BHIB Insurance Brokers Ltd
– Bluefrog Design
– Commala Ltd
– Kaleidoscope Data Privacy Consultants
– Lucid Group
– Oxford Product Design
– The Leicester Life Sciences Accelerator
You will find many other Medilink members exhibiting throughout the expo, along with the Medilink UK stand – B80, so please come along and catch up with the Medilink team.
Click here to view the current online interactive expo floor plan.
*****Limited pod spaces still available on Medilink UK Pavillion exhibition stand*******
To find out more on exhibiting please click here to email Sarah Orme, Rapid News.
Find out more on the show and the benefits click here

Medilink UK Healthcare Virtual Business Awards 2021
2021-10-01 16:00 - 18:00
Join us for the next virtual Medilink UK Healthcare Business Awards 2021 and celebrate the very best of UK Life Sciences companies.
The awards demonstrate the regional depth and national reach of Medilink UK by recognising the achievements of the regional Medilink awards winners for 2020-2021.
Join us for an afternoon of virtual celebrations, be entertained and take the opportunity to celebrate with the best of the best in the life sciences sector, whilst forming new connections with leading professionals on a unique virtual networking platform.
Introducing our host for the afternoon, Stuart Goldsmith.

Stuart Goldsmith’s infectious, amiable banter and effortless charm has seen him become an international award-winning comedian and writer. He’s also the host of the hugely popular Comedian’s Comedian podcast in which he interviews some of the biggest names in live comedy on their experiences performing, the writing process, and life on the road.
Often candid, frequently clever, but always good-natured, as well as becoming a fixture on the live circuit, Stuart has appeared on Alan Davies: As Yet Untitled and ITV’s Show Me The Funny where he reached the semi-finals. He has warmed up for the Graham Norton Show and written for Radio 2’s Out to Lunch.

We are proud to bring you these awards in the following categories:
– Start-Up Award
– Export Achievement Award
– Collaboration with the NHS Award
– Innovation Award
– Outstanding Achievement Award
For the full list of finalists click here
Book Now
Timings: 4pm-5:30pm Award Ceremony, online networking until 6pm
Dial-in details will be provided to delegates by a member of the Medilink Midlands events team once the online registration form has been completed.
Note: These national awards are managed by Medilink Midlands on behalf of Medilink UK
If you have any queries relating to the awards, please click here.

WEBINAR: UK Life Sciences – Opportunity to discuss Government policy with the Office for Life Sciences
2021-10-05 10:00 - 11:00
In this Medilink Midlands webinar, the Office for Life Sciences, the Government’s specialist team covering the sector, are eager to hear the views of Life Sciences businesses on what more the Government can do to support the growth and advancement of the sector.
In this session, the Office for Life Sciences will present on current Government policy in relation to the Life Science sector, and outline the Government’s future plans for the sector. OLS are also very keen to hear from individuals and firms in the sector about what more the Government can do to support the sector.
The insights gained from this webinar will be fed back to Government Ministers and inform future Government policy making in relation to the Life Sciences.
This is an interactive session, with plenty of opportunity for questions, limited presentations, as well as guidance on where to go for further information, support and advice.
TO BOOK YOUR FREE PLACE PLEASE CLICK HERE

Speaker Profile:
Alex Mclaughlin, Head of International Trade and Medical Device Regulation, Office for Life Sciences
Alex is responsible for all of OLS’s work on International Trade and Medical Device Regulation, advising Ministers in the Business and Health Departments.
Prior to his current role, Alex was Senior Private Secretary to two Health Ministers, established the Department’s epidemic vaccines programme, and worked for the Chief Medical Officer.

WEBINAR: The final furlong – your clinical trial data and top tips on regulatory submission
2021-10-06 10:00 - 11:00
Join us for the next in the series of our Clinical Trial Special Interest Groups with Afortiori Development, at this webinar “The final furlong – Your clinical trial data and regulatory submission. Top tips on getting ready for regulatory submission”.
When a trial finishes, the ultimate goal is to have usable data that can be presented to regulators to make your case for your product’s approval. Join us to understand the key considerations you’ll need to be aware of when getting your data ready for regulatory scrutiny.
DURATION: 1 hour
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the SoLSTICE programme, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all.
Speaker Profiles:

Chaired by: Dr Nicola Wall, Chief Executive Officer, Afortiori Development
Nicola co-founded Afortiori Development after a long career in clinical research within a variety of roles. Nicola has extensive experience and a proven track record in global clinical trial management, quality assurance and process management in the healthcare industry. Afortiori have built an impressive global team of clinical trial specialists, clinicians and biostatisticians with experience in adult, paediatric and neonatal clinical research, and both primary and secondary healthcare settings.

Greer Deal, Director, Global Regulatory Services
Greer has over 25 years’ experience in the life science sector and 15 years ago when her husband, Bobby Deal, identified a gap in the market, she co-founded Global Regulatory Services (GRS) and more recently, as part of the company’s expansion, they also established Med-Di-Dia in Ireland. Operating at the forefront of technology GRS is a specialist organisation with worldwide coverage providing solutions to the global life science industry focusing on regulatory affairs, quality compliance and innovation. With a worldwide network of professionals, GRS is able to support companies with emerging, novel technologies from foods to herbals, medical devices to IVDs, pharmaceuticals to regenerative therapies and borderline medicinal products. Greer is passionate about raising the profile of regulatory professionals and highlighting how regulatory affairs is a critical part of a product’s journey from concept to commercialisation and beyond.

IN-PERSON EVENT: Food Supplement Special Interest Group (SIG): Sleep - a holistic approach, where nutrition and supplementation have a role to play
2021-10-07 09:30 - 12:45 | We are Pioneer Group Nottingham, Innovation Building, (formerly BioCity), Pennyfoot Street, Nottingham, NG1 1GF, United Kingdom
With COVID-19 restrictions being eased for business events, we are pleased to be able to offer this in-person event. Please see details below regarding COVID-19 compliance.

***Registration for this event is now closed****
The next Food Supplements Interest Group (SIG) will take place in-person on Thursday 7th October. The SIG will discuss Sleep – a holistic approach, where nutrition and supplementation have a role to play.
Topics to be covered:
*Sleep – some truths and myths explained
*Differentiation between food supplement claims and medicinal claims
*Traditional herbal remedies – why are these so different?
*Botanical food supplements – what are they and how can I use them?
*What is a systems biology approach?
*How are the principles of system biology applied in the world of nutrition?
*A review of known nutrients used for sleep claims using a systems biology lens
*Melatonin medicine or food supplement?
*Dietary considerations
To book, please complete the online booking form below. Due to social distancing, places will be limited. Your application will be reviewed and a member of the events team will be in touch to confirm your place. Unfortunately due to the number of places available, we are only able to offer one place per organisation.
This free to attend event will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £255, but is delivered completely free of charge to participants.

PROGRAMME
SPEAKER PROFILES
DELEGATE LIST
The venue and all participants will be required to adhere to social distancing guidelines at all times. Please see further information below regarding COVID-19 compliance at the venue.
We are Pioneer Group, Nottingham (formerly BioCity):
We are Pioneer Group is accessible by car, train and bus as it is a City Centre venue, on-site parking is not available for delegates, however the Motorpoint Arena Car park is available and located behind the buildings, for details and the address see here.
Venue and event – COVID-19 Compliance
– Delegates must not attend if they are self isolating or displaying any COVID-19 symptoms (a high temperature, new and persistent cough, or a loss of/change in sense of taste or smell), even if these symptoms are mild
– Delegates must not attend if anyone they live with have one of the above symptoms
– An NHS QR code for delegates to check in on will be available
– Delegates/staff have the option to wear a face covering upon entering the venue and whilst in attendance at the event
– The room will be laid out with relevant spacing between tables/delegates
– All rooms will have hand sanitiser nearby
– Social distancing measures will be in effect for all toilets
– Individual boxes will be provided for lunch – with options for Meat eaters, Vegetarian, Vegan and Gluten Free

CANCELLED - WEBINAR: The significant risks & trends affecting the life science sector in a post covid world
2021-10-12 10:00 - 11:00
Join this Medilink Midlands webinar in partnership with BHIB Insurance Brokers for an insight into the current significant risks and trends affecting the life science sector in a post covid world.
The webinar will cover:

Considering the risks & exposures of Virtual Care services

–How to manage and mitigate risks.

Cyber risks & ransomware

–How to manage the devastating threat of ransomware.

The covid effect and hard insurance market in 2021

–Explore the latest issues & trends in the insurance market & how best to navigate these.
You will also be given the opportunity to ask your questions directly to the panel in a Q&A session.
Duration: One hour
Speaker Profiles:

Andy Hall, Corporate Insurance Broker, BHIB Insurance Brokers
Andy has worked in the insurance industry for 22 years and for the last 3 years has headed up the specialist cyber risks division at BHIB insurance brokers working closely with clients and their IT teams to evaluate cyber security risks and recommending the appropriate risk management and insurance solution to meet their needs.

Further profiles to follow

IN-PERSON Event: Medical Technologies Innovation Facility (MTIF) showcase & on-site tour
2021-10-14 09:30 - 13:00 | Medical Technologies Innovation Facility (MTIF), Clifton Campus, NTU, Clifton Lane, Nottingham, Nottinghamshire, NG11 8NS
With COVID-19 restrictions being eased for business events, we are pleased to be able to offer this in person event. Please see details below regarding COVID-19 compliance.

**REGISTRATION FOR THIS EVENT IS NOW CLOSED**

This in-person event in partnership with MTIF will provide an opportunity to find out more about the services available to companies looking to develop medical technologies and an opportunity to embark on a tour of the newly finished research and development building located at Nottingham Trent University’s Clifton Campus.
The event will provide:
-An overview of MTIF and the capabilities on offer
-A review of the partnership with Anthony Nolan Cell and Gene Therapy
-An introduction to one of MTIF’s strategic partners, the Derby Clinical Trials Support Unit
-Opportunity to tour the facility – featuring laboratories, clean rooms and an extensive range of specialist equipment available for use by SMEs
Nottingham Trent University are Proud Patrons of Medilink Midlands, to read more please click here.
Please Note: Whilst this event is free to attend, spaces are limited and priority will be given to members of Medilink.
PROGRAMME
SPEAKER PROFILES
DELEGATE LIST

Venue
MTIF research facility is based at Nottingham Trent University’s (NTU) Clifton Campus, four miles from the city centre. There is a bus route that stops directly outside the facility. On-site parking is available. SAT NAV directions, please use postcode NG11 8NS. For a map and directions please CLICK HERE.
Venue and event – COVID-19 Compliance
– Delegates must not attend if they are self isolating or displaying any COVID-19 symptoms (a high temperature, new and persistent cough, or a loss of/change in sense of taste or smell), even if these symptoms are mild
– Delegates must not attend if anyone they live with have one of the above symptoms
– An NHS QR code for delegates to check in on will be available
– Delegates/staff have the option to wear a face covering upon entering the venue and whilst in attendance at the event
– The room will be laid out with relevant spacing between delegates
– All rooms will have hand sanitiser nearby

VIRTUAL WORKSHOP: Introduction to NHS Market Access
2021-10-21 10:30 - 11:30
REGISTRATION FOR THIS EVENT IS NOW CLOSED
Join our two-part CPD accredited virtual workshop, Introduction to NHS Market Access, delivered by the East Midlands Academic Health Science Network (EMAHSN).
Combined, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS.
PART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you.
The webinar will cover:
– The NHS Structure
– Understanding pathways and cash flow
– Getting your message right
– What support you can expect from the AHSN
——————
PART 2 is a live 1-hour Q&A session that will take place on Thursday 21st October.
In order to gain access to this live session, delegates are required to watch the pre-recorded webinar prior to attending.
The Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team.
Upon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team. Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.

SPEAKER PROFILE:
Live Q&A Chair:

Suzanne Horobin, Head of Innovation Exchange, East Midlands Academic Health Science Network

Pre-recorded Webinar:
Nicholas Brown, Commercial Manager, East Midlands Academic Health Science Network
Nick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this, Nick has more than 20 years’ experience of the medical industry working with manufacturers, distributors and clinical staff from the UK and European health sectors, from both the sales and marketing side, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region .

WEBINAR: 10 months on from Brexit- where are we now?
2021-10-27 10:30 - 11:30
Ten months on from Brexit – we are seeing a set of challenges and opportunities facing the life science sector, a time of technological change across fields like biotech, medtech and AI.
Among the specific challenges are the new, dual systems for mainland UK and Northern Ireland, with NI needing to apply regulations flowing from Brussels. Sales in NI may require new Economic Operator arrangements, for example.
Alongside these challenges, the UK is finding its feet in developing its own systems and structures. Opportunities like a more flexible and permissive regulatory model, involving acceptance of goods approved elsewhere subject to proportionate, risk-based controls, could see a reduced regulatory burden, especially for smaller innovators. The fresh approach proposed in the Taskforce on Innovation, Growth and Regulatory Reform report offers a prospect of real benefits to industry.
Businesses across the sector also continue to face challenges and opportunities in recruiting and retaining talented staff. These include the new (but continually) evolving points based immigration system, competition for the best people, and staff engagement – all in the context of new ways of working as we begin to emerge from the Covid-19 lockdown.
Join Mills & Reeve at this webinar to hear from James Fry, Isabel Teare and Tracy Yates as they consider the above challenges plus providing the opportunity for you to ask questions.
DURATION: 1 hour
Speaker Profiles:

James Fry, Head of Life Sciences and Partner at Mills & Reeve
James heads the firm’s fast growing, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech, medical device, diagnostic, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property, commercial contracting and regulatory work.

Isabel Teare, Senior Legal Adviser at Mills & Reeve
Isabel Teare is a Senior Legal Adviser at Mills & Reeve. She started her career in molecular biology, and focuses on all aspects of life sciences law and regulation.

Tracy Yates, Consultant, Mills & Reeve
Tracy is an employment lawyer since with a business focused immigration specialism since. She has a wide experience of changing economic, political and legal environments. She provides support and advice to leading regional organisations including those in the life sciences sector.

*Cancelled *Virtual Workshop: Is your Business Case NHS Ready?
2021-11-02 13:30 - 14:30
Unfortunately this event has been cancelled due to unforeseen circumstances. Please accept our apologies for any inconvenience this may cause.

Join the second of our two-part CPD accredited virtual workshops, Is your Business Case NHS Ready?, delivered by the East Midlands Academic Health Science Network (EMAHSN).
The challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case.
PART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you.
The webinar will cover:
– What a business case is, what is its purpose and why is it so important?
– Who reviews the business case and how are they evaluated?
– How to construct a good business case
——————
PART 2 is a live 1-hour Q&A session that will take place on Tuesday 2nd November.
In order to gain access to this live session, delegates are required to watch the pre-recorded webinar prior to attending, by close of play on Monday 1st November
The Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team.

Upon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team. Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.
LIVE Q&A PANEL:
Julian Patel, Commercial Manager, EMAHSN (CHAIR)

Tim Robinson, Commercial Director, EMAHSN

SPEAKER PROFILE (WEBINAR):

Nicholas Brown, Commercial Manager, East Midlands Academic Health Science Network
Nick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this, Nick has more than 20 years’ experience of the medical industry working with manufacturers, distributors and clinical staff from the UK and European health sectors, from both the sales and marketing side, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad, providing wealth creation opportunities across the East Midlands.

WEBINAR: Digital Technology and the Future of Healthcare
2021-11-11 10:00 - 11:00
This webinar will explore how digital technologies have been used during the pandemic and consider the potential for driving change in health and social care provision.
The potential of ‘big data’ approaches are increasingly being recognised, and the value of people’s data signatures as indicators of activity, well-being, and broader social trends is being explored in various healthcare settings.
Hosted by Medilink Midlands, this webinar will feature speakers from De Montfort University’s Digital Health research team and partner organisation Howz. Howz is a member of TSA, the industry body for Technology Enabled Care (TEC), representing the largest industry specific network in Europe and bringing together a growing membership of organisations across local government, health and the private sector.
Key areas explored at the webinar will include:
• Findings from an ongoing project on using a smart-meter app to detect electricity usage patterns within the home, and the potential to identify significant changes in an individual’s physical ability.
• Capacity for digital technology to enhance health and well-being.
• The long-term trends of digital technology in healthcare.
This free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the SoLSTICE programme, attendance is not restricted to companies in the LLEP area and is open to all.

Speaker Profiles

Dr Simon Oldroyd, Interim Deputy Vice-Chancellor
Dr Simon Oldroyd became Interim Deputy Vice-Chancellor in April 2019. Prior to this he had been PVC/Dean for the Faculty of Health and Life Sciences since February 2015 and Deputy Dean to the faculty since October 2011.

Professor Bertha Ochieng, Professor of Integrated Health and Social Care, DMU
Bertha Ochieng is Professor of Integrated Health and Social Care, Faculty of Health and Life Sciences, De Montfort University. A key aspect of her research is in examining digital solutions that support development of integrated models of health and social care and community engagement.

Professor Ivan Browne, Director of Public Health at Leicester City Council
Ivan Browne is the Director of Public Health at Leicester City Council and has been spearheading the local response to COVID 19 in the City. He is a professor of public health practice with De Montfort University and has a particular interest in the potential of digital technologies to improve population health and wellbeing.

Louise Rogerson, Chief Operating Officer, Howz
Louise Rogerson is a physiotherapist with 18 years experience working within the NHS as a frontline clinician, operational service manager, and latterly as a commissioner. As a commissioner Louise was responsible for development of healthcare service pathways at a population level including stroke, palliative care, and CVD. Seeing the data available to her as a commissioner Louise realised that more needed to be done to fill the data gap for older people to enable access to support services before they hit crisis point.
As Chief Operating Officer for Howz, Louise is responsible for the customer experience, building partnerships, project management, and team development. Howz describes the daily routine for an individual through smart meter data and other sensors and aims to detect changes earlier. Louise is part of the Surrey NHS project management team providing expertise in both development and implementation of remote monitoring. Louise also continues to run her own practice as a physiotherapist with a special interest in neurology and older people.

This webinar is part of Leicester Business Festival 8-18th November. For further details please click here.

Pharma Integrates 2021
2021-11-16 08:00 - 17:00
Focused on pharma and healthcare senior leadership
Broadcast live online on the 16th of November 2021, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
This year the three core themes for the event are:
People – How do we ensure our people have the right skills and support to succeed? How do we develop the best partnerships and engage with patients?
Processes – How can we adapt our processes to accelerate the development and delivery of medicines?
Predictions – How can we predict future pharma needs and prevent the next pandemics? How can we use the current focus on pharma to demystify medicines?
MEDILINK MEMBERS OFFER: As a partner of Pharma Integrates, Medilink have secured a limited number of complementary tickets for Medilink Members. Please contact us by 17:00 on 11 November 2021 to obtain a promo code to obtain your free ticket – click here.
Please note: The complimentary tickets are on a first come, first served basis. Registrations cannot be accepted after this date of 11 November.
To find more information, register and to view the agenda and high-profile speakers, please click here.

IN-PERSON EVENT: Medilink Midlands Annual General Meeting (AGM)
2021-11-16 14:30 - 16:00 | Room SCT153, Birmingham City University, Seacold Building, City South Campus - School of Health Sciences, Westbourne Road, Birmingham, B15 3TN
The Medilink Midlands Annual General Meeting (AGM) will take place on Tuesday 16 November from 2.30 pm – 4.00 pm.
Hosted at the School of Health Sciences, at Medilink patron Birmingham City University, City South Campus.
Following the formal presentations, you will have the chance to meet and network with fellow members and representatives from the Board of Directors.
You will also hear from our members sharing their recent experiences and how they have benefited from their membership.
At the end of the formal proceedings, guests will have the opportunity for an optional tour of the School of Health Sciences facilities (4pm-4:30pm).
We’re looking forward to seeing our members in person and hope you can join us.
Please note: Non-members are welcome to attend the AGM.
To book your place, please complete the online booking form below.
Book Now
Once your booking form has been received a member of the events team will be in touch to confirm your place, please note this is not an automated system

WEBINAR: An update on current changes to MDR, IVDR & Role of the Person Responsible (PRRC)
2021-11-17 10:00 - 11:30
The next MedTech Regulatory Special Interest Group (SIG), hosted by regulatory affairs expert Ben Jacoby, from Cambridge RA Ltd, will provide a comprehensive update on the current Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) landscape, plus an overview of the requirements and practical considerations needed within a company to meet regulatory compliance.
The next MedTech Regulatory Special Interest Group (SIG), hosted by regulatory affairs expert Richard Young, from AcclaimBiomedical Consulting Ltd, will provide a comprehensive update on the current Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) landscape, plus an overview of the requirements and practical considerations needed within a company to meet regulatory compliance.
Ben will be joined by Anne Jury, a regulatory affairs consultant with over 18 years experience in the medical and diagnostic healthcare products industries, and Alexander Pearce, Educo Life Sciences, well experienced in helping medical device professionals develop their skills and knowledge through learning and development.
During the presentations, they will cover:
– Introduction to current changes to requirements MDR & IVDR
– ISO13485 minimum Quality Management Systems (QMS) requirements
– Clinical Evidence
– General Safety and Performance Requirements (GSPR)
– Lay Users (individuals who do not have formal education in a relevant field of healthcare or medicine display)
– Roles of the Person Responsible for Regulatory Compliance (PRRC)
– There will be time at the end of the presentations for a Q&A session. Please submit any questions in advance for the panel to discuss during the presentation on the online booking form.
CLICK HERE TO SECURE YOUR PLACE
This free-to-attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £190, but is delivered completely free of charge to participants.
Please note: whilst this event is held as part of the ACTIS programme, attendance is not restricted to companies in the SEMLEP area and is open to all.
Duration: 1 hour and 30 minutes
Speaker Profiles:

Ben Jacoby, Director, Cambridge RA Ltd
Ben is an experienced regulatory consultant who has worked with clients in the diagnostic, medical device and pharmaceutical industries to help them bring innovative products to market. He provides regulatory and strategic guidance on EU, UK and US issues to clients. Core competencies include technical files, Clinical studies; EU and UK legislation including IVD’s, companion diagnostics and medical devices; EU legislative requirements for instruments; and classification of devices. With more than 25 years of experience in regulatory affairs, he was a European-authorized representative at Ortho-Clinical Diagnostics (a Johnson & Johnson company at the time). He is an effective partner in project management and in achieving goals and deadlines. He is a skilled and persuasive communicator with clients and colleagues at all levels; and flexible and adaptable to changing environments and business needs. Ben has a PhD in Biochemistry from the University of London.

Alexander Pearce, MBA | Director of Educo Life Sciences
Alexander is the Director of Educo Life Sciences, designing learning programmes to meet the needs of life science professionals. He is a specialist in learning product development and was previously Product Manager for a leading Life Science training organisation. He has extensive knowledge of learning pathways, content creation and digital training solutions and was responsible for managing a portfolio of over 300 courses. He was instrumental in designing and delivering online learning solutions.
Alexander is a firm believer that technical training can be delivered in an interactive and impactful way to avoid it being repetitive and boring. He believes training solutions that combine online learning tools and techniques with face-to-face learning delivers greater improved skill retentions and performance.
Alexander has a BSc in Medical Physiology and an MBA from the University of Leicester.

Anne Jury, Director of Anne Jury Associates, Medical Devices Regulatory Affairs Consultancy
Anne Jury is a consultant and trainer in medical devices EU & UK regulatory compliance and quality assurance systems. Starting out as a company microbiologist for Smith & Nephew Textiles Anne went on to work for Notified Bodies, BSI and then TÜV Product Service as a lead auditor and later as UK Regional Manager.
Anne has run her own consultancy business since 2000 providing medical device regulatory support to companies ranging from research institutes and start-up companies to SMEs and multi-national market leaders. Anne was one of the founders and visiting lecturers to the MSc in Medical Technology Regulatory Affairs run by TOPRA and Cranfield University where she was also an external examiner from 2009 to 2012. Anne is also a course leader for Educo Life Sciences, the learning and development specialist, since 2020. Anne is Vice-President of Team-PRRC, a non-profit organization set up in March 2020 to support individuals in the role of PRRC under the EU medical device regulations.
